1. Surgical outcomes in 13 patients with bronchopulmonary carcinoid tumors including one recurrent oncocytic carcinoid tumor
- Author
-
Ryujiro Sugimoto, Norihiro Teramoto, Kentaro Nakata, Yoshifumi Sugawara, Rieko Nishimura, Tsuyoshi Ueno, Yuho Maki, and Motohiro Yamashita
- Subjects
Adult ,Male ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Lung Neoplasms ,Carcinoid tumors ,Carcinoid Tumor ,Oncocyte ,030204 cardiovascular system & hematology ,Metastasis ,03 medical and health sciences ,0302 clinical medicine ,Fluorodeoxyglucose F18 ,Surgical oncology ,medicine ,Humans ,neoplasms ,Aged ,Retrospective Studies ,Fluorodeoxyglucose ,business.industry ,Standard treatment ,General Medicine ,Middle Aged ,medicine.disease ,Primary tumor ,digestive system diseases ,Survival Rate ,Treatment Outcome ,030228 respiratory system ,Cardiothoracic surgery ,Positron-Emission Tomography ,Female ,Surgery ,Radiology ,Neoplasm Recurrence, Local ,Tomography, X-Ray Computed ,Cardiology and Cardiovascular Medicine ,business ,medicine.drug - Abstract
Bronchopulmonary carcinoids are low-grade tumors for which the standard treatment is surgical resection. We retrospectively evaluated the surgical outcomes. Thirteen patients underwent surgical resection for them at our institution between January 2005 and December 2016. We collected their clinicopathologic data to evaluate surgical outcomes. The 13 patients comprised seven men and six women. Complete resection was performed in all cases. All the tumors were typical carcinoids, including one oncocytic carcinoid which showed highest fluorodeoxyglucose (FDG) uptake (SUVmax 45.7). The 5-year overall survival rates were 100%. The only patient with oncocytic carcinoid developed recurrence of liver metastasis 49 months after the primary lung resection. The metastasis showed low FDG uptake (SUVmax 2.8) and its histology was typical carcinoid and not oncocytic carcinoid. Surgical outcomes in our patients were favorable. In oncocytic carcinoid, metastatic site may have a radiologic and histologic appearance different from the primary tumor.
- Published
- 2018